Alto Pharmacy key facts
- Alto Pharmacy is a telehealth pharmacy that aims to make the prescription experience easier for people seeking a healthier life.
- Alto Pharmacy’s last known valuation is $800.0M.
- It has raised $760.0M.
- Notable investors include Gaingels.
Who backs Alto Pharmacy
1- ·Watch Alto Pharmacy: the Monday email on marks, rounds and moves
Alto Pharmacy funding rounds
No funding rounds for Alto Pharmacy are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Alto Pharmacy valuation
Alto Pharmacy's last known valuation is $800 million. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.
Alto Pharmacy investors
1 investor is on record for Alto Pharmacy, including Gaingels. By type, the record holds 1 venture capital firm.
About Alto Pharmacy
Alto Pharmacy is a telehealth pharmacy that aims to make the prescription experience easier for people seeking a healthier life. The dedicated team of pharmacists, engineers, and care specialists at Alto tirelessly work towards raising the standards of pharmacy services. As a prescription management partner, Alto provides delivery, advice, discounts, and on-call support to patients. With a focus on the crucial role of pharmacists in healthcare journeys, Alto combines expert pharmacist care with purpose-built technology to offer a convenient and affordable medication experience.
- Founded
- 2015
- Employees
- 810
- Website
- alto.com
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
Alto Pharmacy’s last known valuation. A PrivateMarketView mark is published once fund marks, secondary prints or a priced round let us confirm it.